A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.
Clinical trial NCT05181709 · COMPLETED
Trial details
- NCT number
- NCT05181709
- Sponsor
- Sean Liu
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-09
- Primary completion
- 2023-05-03
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.